A detailed history of Rhumbline Advisers transactions in Arcellx, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 60,570 shares of ACLX stock, worth $5.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,570
Previous 53,002 14.28%
Holding current value
$5.9 Million
Previous $3.69 Million 9.33%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$49.74 - $66.98 $376,432 - $506,904
7,568 Added 14.28%
60,570 $3.34 Million
Q1 2024

May 09, 2024

BUY
$51.85 - $73.49 $81,248 - $115,158
1,567 Added 3.05%
53,002 $3.69 Million
Q4 2023

Feb 08, 2024

BUY
$31.75 - $57.99 $2,635 - $4,813
83 Added 0.16%
51,435 $2.85 Million
Q3 2023

Nov 09, 2023

BUY
$31.51 - $37.4 $29,083 - $34,520
923 Added 1.83%
51,352 $1.84 Million
Q2 2023

Aug 08, 2023

BUY
$27.49 - $46.9 $107,623 - $183,613
3,915 Added 8.42%
50,429 $1.59 Million
Q1 2023

May 11, 2023

BUY
$26.92 - $33.94 $94,893 - $119,638
3,525 Added 8.2%
46,514 $1.43 Million
Q4 2022

Feb 14, 2023

BUY
$17.18 - $33.0 $87,033 - $167,178
5,066 Added 13.36%
42,989 $1.33 Million
Q3 2022

Nov 10, 2022

BUY
$16.67 - $22.04 $388,827 - $514,083
23,325 Added 159.78%
37,923 $712,000
Q2 2022

Aug 11, 2022

BUY
$7.21 - $24.43 $105,251 - $356,629
14,598 New
14,598 $264,000

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $4.27B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.